揭开肥胖症:对转录基因数据的五年综合性审查
Svetlana Tarbeeva1, Anna Kliuchnikova1, Anna Kozlova1
1Institute of Biomedical Chemistry, 119121 Moscow, Russia.
International journal of molecular sciences
|November 27, 2025
概括
最近的OMICS研究揭示了人类肥胖的主要分子驱动因素,包括免疫激活和代谢失调. 综合性分析对于开发个性化肥胖治疗非常重要.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 代谢学 代谢学 代谢学
背景情况:
- 人类肥胖是一种复杂的疾病,具有多方面的分子基础.
- 奥米克技术为解剖这些分子机制提供了强大的工具.
研究的目的:
- 审查2020年1月至2025年6月期间发表的关于人类肥胖的转录组研究.
- 为了确定融合的分子主题,并评估多omics集成的实用性.
主要方法:
- 使用人类组织或细胞系进行的高通量RNA测序研究的系统审查.
- 分析了三个融合的主题:免疫炎症激活,代谢途径失调和表观遗传/转录后调节.
- 评估多主题整合方法.
主要成果:
- 确定了与胰岛素抵抗和内脏脂肪相关的免疫-炎症激活 (干扰素刺激的基因,先天免疫).
- 观察到脂质和能量代谢的失调,包括减少脂解和β-氧化.
- 突出表观遗传修饰 (DNA甲基化,基因素修饰) 和非编码RNAs (lncRNAs,miRNAs,circRNAs) 的参与.
- 多学科整合对机械洞察力和生物标志物发现有希望,但面临着由队列异质性和技术变异性带来的挑战.
结论:
- 在具有良好特征的纵向人类队伍中进行标准化,整合性的多学科分析至关重要.
- 将分子特征转化为强大的生物标志物和针对肥胖的个性化治疗策略需要进一步的研究.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
228
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
228
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
162
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
162
Regulation of Metabolism
11.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.4K
Regulation of Food Intake
2.3K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.3K
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K


